Quantify’s Emma Söreskog, Ingrid Lindberg, Oskar Ström and Fredrik Borgström have co-authored two recently published papers on cost-effectiveness modelling in osteoporosis. One of the papers presents a […]
A new systematic literature review on patient quality of life in Alzheimer’s disease is now published. The study was co-authored by Anders Gustavsson and is part of the Innovative Medicines Initiative project […]
Quantify’s Ingrid, Mathias and Kirk are co-authors on an population-based Swedish RWE study of incidence of psoriaticarthritis in adults with skin psoriasis published in Acta D-V, and presented at AAD2020. The results showed that if 10,000 patients with skin psoriasis […]
Anders Gustavsson is co-author of a recently published Alzheimer study presenting a cross-walk between the generic health utility measure EQ5D and the disease specific health-related quality of life measure QoL-AD.
A free full text version is available here.
The paper “Association of Skin Psoriasis and Somatic Comorbidity With the Development of Psychiatric Illness in a Nationwide Swedish Study” by Quantify’s Kirk Geale and coauthors has been published in JAMA Dermatology. […]
The abstract “Persistence of biologic treatment in psoriatic arthritis: A population-based study in Sweden”, co-authored by Quantify’s Kirk Geale, Ingrid Lindberg and Emma Paulsson, has been accepted for oral presentation at EULAR 2020 E-Congress on June 3rd at 16:30-16:35, Session […]
The paper “Statin Dose Titration Patterns and Subsequent Major Cardiovascular Events in very High-Risk Patients – Estimates from Swedish Population-based Registry Data”, co-authored by Quantify’s Jonas Banefelt and Maria Lindh has been published in European Heart Journal – Quality of […]
The paper ‘Fragility fractures in Europe: burden, management and opportunities’, co-authored by Quantify’s Fredrik Borgström, Linda Karlsson, Gustaf Ortsäter and Nicholas Norton, has been published in Archives of Osteoporosis.
The paper ‘Cost-Effectiveness Analysis of Patiromer in Combination with Renin–Angiotensin–Aldosterone System Inhibitors for Chronic Kidney Disease in Sweden’, co-authored by Quantify, has been published in PharmacoEconomics. Read the full article here.
The paper ‘Real-world effectiveness of osteoporosis treatment in the oldest old’, co-authored by Quantify’s Oskar Ström, Rosa Lauppe, and Gustaf Ortsäter, has been published in Osteoporosis International.